These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 25205475

  • 1. Epstein-Barr virus encoded microRNAs target SUMO-regulated cellular functions.
    Callegari S, Gastaldello S, Faridani OR, Masucci MG.
    FEBS J; 2014 Nov; 281(21):4935-50. PubMed ID: 25205475
    [Abstract] [Full Text] [Related]

  • 2. The Epstein-Barr virus miR-BHRF1-1 targets RNF4 during productive infection to promote the accumulation of SUMO conjugates and the release of infectious virus.
    Li J, Callegari S, Masucci MG.
    PLoS Pathog; 2017 Apr; 13(4):e1006338. PubMed ID: 28414785
    [Abstract] [Full Text] [Related]

  • 3. Regulation network and expression profiles of Epstein-Barr virus-encoded microRNAs and their potential target host genes in nasopharyngeal carcinomas.
    Zeng Z, Huang H, Huang L, Sun M, Yan Q, Song Y, Wei F, Bo H, Gong Z, Zeng Y, Li Q, Zhang W, Li X, Xiang B, Li X, Li Y, Xiong W, Li G.
    Sci China Life Sci; 2014 Mar; 57(3):315-326. PubMed ID: 24532457
    [Abstract] [Full Text] [Related]

  • 4. An Epstein-Barr Virus MicroRNA Blocks Interleukin-1 (IL-1) Signaling by Targeting IL-1 Receptor 1.
    Skinner CM, Ivanov NS, Barr SA, Chen Y, Skalsky RL.
    J Virol; 2017 Nov 01; 91(21):. PubMed ID: 28794034
    [Abstract] [Full Text] [Related]

  • 5. Role of Viral and Host microRNAs in Immune Regulation of Epstein-Barr Virus-Associated Diseases.
    Iizasa H, Kim H, Kartika AV, Kanehiro Y, Yoshiyama H.
    Front Immunol; 2020 Nov 01; 11():367. PubMed ID: 32194570
    [Abstract] [Full Text] [Related]

  • 6. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS, Selemon H, Elton SM, Parinandi NL.
    Gene; 2013 Dec 10; 532(1):1-12. PubMed ID: 23246696
    [Abstract] [Full Text] [Related]

  • 7. Genetics of Epstein-Barr virus microRNAs.
    Klinke O, Feederle R, Delecluse HJ.
    Semin Cancer Biol; 2014 Jun 10; 26():52-9. PubMed ID: 24602823
    [Abstract] [Full Text] [Related]

  • 8. Identification and validation of the cellular targets of virus-encoded microRNAs.
    Kok KH, Lei T, Jin DY.
    Methods Mol Biol; 2010 Jun 10; 667():319-26. PubMed ID: 20827543
    [Abstract] [Full Text] [Related]

  • 9. HBV-encoded microRNA candidate and its target.
    Jin WB, Wu FL, Kong D, Guo AG.
    Comput Biol Chem; 2007 Apr 10; 31(2):124-6. PubMed ID: 17350341
    [Abstract] [Full Text] [Related]

  • 10. [Research Advances in Target Genes of Epstein-Barr Virus-encoded MicroRNAs].
    Gao L, Ai J, Xie Z, Shen K.
    Bing Du Xue Bao; 2016 Mar 10; 32(2):229-34. PubMed ID: 27396169
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr Virus BGLF2 commandeers RISC to interfere with cellular miRNA function.
    Campbell AM, De La Cruz-Herrera CF, Marcon E, Greenblatt J, Frappier L.
    PLoS Pathog; 2022 Jan 10; 18(1):e1010235. PubMed ID: 35007297
    [Abstract] [Full Text] [Related]

  • 12. Epstein-Barr virus circRNAome as host miRNA sponge regulates virus infection, cell cycle, and oncogenesis.
    Qiao Y, Zhao X, Liu J, Yang W.
    Bioengineered; 2019 Dec 10; 10(1):593-603. PubMed ID: 31668120
    [Abstract] [Full Text] [Related]

  • 13. SUMOylation of the m6A reader YTHDF2 by PIAS1 promotes viral RNA decay to restrict EBV replication.
    Sugiokto FG, Saiada F, Zhang K, Li R.
    mBio; 2024 Feb 14; 15(2):e0316823. PubMed ID: 38236021
    [Abstract] [Full Text] [Related]

  • 14. SUMOylation and cell signalling.
    Andreou AM, Tavernarakis N.
    Biotechnol J; 2009 Dec 14; 4(12):1740-52. PubMed ID: 19946876
    [Abstract] [Full Text] [Related]

  • 15. Plasma viral microRNA profiles reveal potential biomarkers for chronic active Epstein-Barr virus infection.
    Kawano Y, Iwata S, Kawada J, Gotoh K, Suzuki M, Torii Y, Kojima S, Kimura H, Ito Y.
    J Infect Dis; 2013 Sep 01; 208(5):771-9. PubMed ID: 23687223
    [Abstract] [Full Text] [Related]

  • 16. Epstein-Barr virus (EBV) microRNAs: involvement in cancer pathogenesis and immunopathology.
    Lopes LF, Ruiz Miyazawa KW, de Almeida ER, Serafim KG, de Almeida Gualtieri K, Costa IC, Felipe I, Pavanelli WR, Watanabe MA.
    Int Rev Immunol; 2013 Jun 01; 32(3):271-81. PubMed ID: 23617690
    [Abstract] [Full Text] [Related]

  • 17. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH, Wolf H, Minarovits J.
    Autoimmunity; 2008 May 01; 41(4):298-328. PubMed ID: 18432410
    [Abstract] [Full Text] [Related]

  • 18. Identification of virus-encoded microRNAs.
    Pfeffer S, Zavolan M, Grässer FA, Chien M, Russo JJ, Ju J, John B, Enright AJ, Marks D, Sander C, Tuschl T.
    Science; 2004 Apr 30; 304(5671):734-6. PubMed ID: 15118162
    [Abstract] [Full Text] [Related]

  • 19. Lytic cycle switches of oncogenic human gammaherpesviruses.
    Miller G, El-Guindy A, Countryman J, Ye J, Gradoville L.
    Adv Cancer Res; 2007 Apr 30; 97():81-109. PubMed ID: 17419942
    [Abstract] [Full Text] [Related]

  • 20. HIV-1 encoded candidate micro-RNAs and their cellular targets.
    Bennasser Y, Le SY, Yeung ML, Jeang KT.
    Retrovirology; 2004 Dec 15; 1():43. PubMed ID: 15601472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.